Abstract
Purpose
To evaluate the relationship among aFT, cFT, and total testosterone (TT) and the best method in diagnosing subnormal levels of TT.
Methods
A total of 213 men were analyzed. Fasting blood samples were drawn for the determination of the lipid profile as well as of plasmatic glucose and serum levels of albumin, TT, aFT, and sex hormone-binding globulin (SHBG). The values of cFT were determined by Vermeulen’s formula.
Results
No correlation between aFT and cFT was observed (r = 0.062; P = 0.368), except after controlling for confounders (r = 0.188; P = 0.007). Only 44.8% of hypogonadal men (TT ≤ 300 ng/dL) were classified by aFT, whereas 72.4% of hypogonadal men were classified by both TT and cFT. Sensitivity, specificity, positive and negative predictive values, and positive likelihood ratio were greater in cFT when compared with aFT.
Conclusions
Our results suggest that cFT is more accurate in diagnosing subnormal levels of TT. Furthermore, we do not recommend using aFT due to its lack of accuracy. Further studies should be performed in order to evaluate the correlation between aFT and cFT with clinical signs and symptoms of androgen deficiency.
Similar content being viewed by others
References
Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ et al (2009) Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl 30:1–9
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS et al (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 95:2536–2559
Morley JE, Patrick P, Perry HM III (2002) Evaluation of assays available to measure free testosterone. Metabolism 51:554–559
Okamura K, Ando F, Shimokata H (2005) Serum total and free testosterone level of Japanese men: a population-based study. Int J Urol 12:810–814
Carruthers M, Trinick TR, Wheeker MJ (2007) The validity of androgen assays. Aging Male 10:165–172
Gheorghiu I, Moshyk A, Lepage R, Ahnadi CE, Grant AM (2005) When is bioavailable testosterone a redundant test in the diagnosis of hypogonadism in men? Clin Biochem 38:813–818
Lepage R (2006) Measurement of testosterone and its sub-fractions in Canada. Clin Biochem 39:97–108
Pardridge WM (1986) Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab 15:259–278
Mendel CM (1989) The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 10:232–274
Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H (2007) Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society Position Statement. J Clin Endocrinol Metab 92:405–413
Ly LP, Sartorius G, Hull L, Leung A, Swerdloff RS, Wang C et al (2010) Accuracy of calculated free testosterone formulae in men. Clin Endocrinol (Oxf) 73:382–388
Sodergard R, Backstrom T, Shanbhag V, Carstensen H (1982) Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 16:801–810
Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666–3672
Nanjee MN, Wheeler MJ (1985) Plasma free testosterone—is an index sufficient? Ann Clin Biochem 22:387–390
Ly LP, Handelsman DJ (2005) Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol 152:471–478
Sartorius G, Ly LP, Sikaris K, McLachlan R, Handelsman DJ (2009) Predictive accuracy and sources of variability in calculated free testosterone estimates. Ann Clin Biochem 46:137–143
Rosner W (1997) Errors in the measurement of plasma free testosterone. J Clin Endocrinol Metab 82:2014–2015
Winters SJ, Kelley DE, Goodpaster B (1998) The analog free testosterone assay: are the results in men clinically useful? Clin Chem 44:2178–2182
Rosner W (2001) An extraordinarily inaccurate assay for free testosterone is still with us. J Clin Endocrinol Metab 86:2903
Christ-Crain M, Meier C, Huber P, Zimmerli L, Trummler M, Müller B (2004) Comparison of different methods for the measurement of serum testosterone in the aging male. Swiss Med Wkly 134:193–197
Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D et al (2004) Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525–533
Fritz KS, McKean AJS, Nelson JC, Wilcox RB (2008) Analog-based free testosterone test results linked to total testosterone concentrations, not free testosterone concentrations. Clin Chem 54:512–516
Moreno SA, Shyam A, Morgentaler A (2010) Comparison of free testosterone results by analog radioimmunoassay and calculated free testosterone in an ambulatory clinical population. J Sex Med 7:1948–1953
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW et al (2005) Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans. A statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45:142–161
American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62–S69
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
Audet AM, Goodnoughf LT, Parvint CA (1996) Evaluating the appropriateness of red blood cell transfusions: the limitations of retrospective medical record reviews. Int J Qual Health Care 8:41–49
de Ronde W, van der Schouw YT, Pols HAP, Gooren LJG, Muller M, Grobbee DE et al (2006) Calculation of bioavailable and free testosterone in men: a comparison of 5 published algorithms. Clin Chem 52:1777–1784
Fiers T, Kaufman JM (2010) http://www.issam.ch/freetesto.htm. Accessed in: September, 2nd, 2010
Knottnerus JA, van Weel C, Muris JWM (2002) Evaluation of diagnostic procedures. BMJ 324:477–480
Acknowledgments
Halmenschlager is supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—CAPES. We thank Federal University of Health Sciences of Porto Alegre (UFCSPA) for financial support.
Conflict of interest
The authors declare that they have no conflict of interest. This article is intended for publication in the Urology section.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Halmenschlager, G., Rhoden, E.L. & Riedner, C.E. Calculated free testosterone and radioimmunoassay free testosterone as a predictor of subnormal levels of total testosterone. Int Urol Nephrol 44, 673–681 (2012). https://doi.org/10.1007/s11255-011-0066-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-011-0066-z